TYAVAX

This brand name is authorized in France.

Active ingredients

The drug TYAVAX contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Hepatitis A, inactivated vaccine UNII `G54MT8V18G` - HEPATITIS A VIRUS
	Inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminum hydroxyphosphate sulphate.
	Read more about Hepatitis A, inactivated vaccine
`2`	Typhoid purified polysaccharide antigen UNII `7194H8W3KT` - SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
	Read more about Typhoid purified polysaccharide antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07CA10	Typhoid-hepatitis A	J Antiinfectives for systemic use → J07 Vaccines → J07C Bacterial and viral vaccines, combined → J07CA Bacterial and viral vaccines, combined
Discover more medicines within J07CA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	69725264

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.